Miyamoto Y, Takeshita M, Izuo M
Gan To Kagaku Ryoho. 1986 Oct;13(11):3229-35.
Using the Su-PS skin test, an attempt was made to evaluate whether or not this reaction could become a useful immune parameter in patients with gastrointestinal cancer. The conclusions were as follows: Late-stage patients with gastric cancer showed a weak response in the Su-PS skin test when examined preoperatively. The skin reaction to Su-PS was shown to become stronger than in the PPD and PHA test when patients received OK-432 treatment. Patients with advanced cancer having longer survival (more than 7 months) showed stronger response in the Su-PS skin test that patients having short survival (less than 6 months). It was suggested that the Su-PS skin test was useful for evaluating the immune response to OK-432 treatment.
利用Su-PS皮肤试验，尝试评估这种反应能否成为胃肠癌患者有用的免疫参数。结论如下：胃癌晚期患者术前接受检查时，在Su-PS皮肤试验中表现出较弱的反应。当患者接受OK-432治疗时，对Su-PS的皮肤反应比在PPD和PHA试验中更强。生存期较长（超过7个月）的晚期癌症患者在Su-PS皮肤试验中的反应比生存期较短（少于6个月）的患者更强。有人提出，Su-PS皮肤试验有助于评估对OK-432治疗的免疫反应。
